Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selective Clonal Regression After Interferon Therapy in Metastatic Melanoma.

The American Journal of dermatopathology - 1 Jan 2025

Fernandez-Flores Angel

Abstract excerpt

ABSTRACT: Regression (total or partial) is a common phenomenon in melanoma. From a pathogenic perspective, it is highly complex and only partially understood, involving aspects of both the tumor and the individual. One of the determining factors is the clonal selection of the tumor, wherein some clones within the tumor survive while others perish. This clonal selection can sometimes occur as a selective mechanism...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to GTP Phosphohydrolases
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Melanoma

Share to Membrane Proteins

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Share to Treatment Outcome

Source

Identifiers

PMID: 39481030
DOI: 10.1097/DAD.0000000000002873

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Selective Clonal Regression After Interferon Therapy in Metastatic Melanoma.PMID 39481030Read ↗

Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating LymphocytesSemantic proximity Read ↗

A phenotype-based cell culture model of melanoma cells that persist as residual disease after therapies leading to recurrenceSemantic proximity Read ↗

Clonal persistence and evolution during a decade of recurrent melanoma.Semantic proximity Read ↗

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesSemantic proximity Read ↗

Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series.Semantic proximity Read ↗

A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutationSemantic proximity Read ↗

Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review)Semantic proximity Read ↗

Selective Growth, In Vitro and In Vivo, of Individual T Cell Clones from Tumor-Infiltrating Lymphocytes Obtained from Patients with MelanomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.